Indian Science Technology and Engineering facilities Map
 
Preivious Next  

  Digital Catalogue for Technology and Products Development


   Technology and Product Development

    Basic Information

Technology developed: Nanoparticulate Formulation for Diagnosis and or Treatment of Cancer (TP19761787314)
Category: Product (Hardware/Material/Software)
Details of Inventor(s):
Inventor Institution/Organization/Company Department Designation
Dr. Dhirendra S. Katti IIT Kanpur Biological Sciences & Bioengineering Faculty Member
Technical Application Area: Biotechnology
If 'Other', please specify:
Please give more details of new technical application area:
Organization(s):
Indian Institute of Technology (IIT) Kanpur
Affiliated Ministry: MHRD, Govt. of India
Type of technology development: Indigenous
Does the technology help in replacing any import items currently
procured from outside India?
Does the technology have export potential? 1
Category of Technology developed: Futuristic
Stage of Development: Lab-Scale
Please describe in detail including the TRL Level:
TRL Level 5

    Abstract:

Applications: The present invention relates to a targeted multimodal formulation comprising mesoporous nanoparticle having a pH responsive coating and an aptamer(s) conjugated to said mesoporous nanoparticle, the pH responsive coating is optionally carboxylated. The formulation may further comprise an anticancer agent.
Advantages: 1. The present invention relates to a nanoparticulate formulation for diagnosis and treatment of cancer. In particular, the formulation is for diagnosis and treatment of triple negative breast cancer (TNBC). 2. Accordingly, an object of the present invention is to provide a reliable targeted multimodal formulation, which target and kill cancer cells at a higher efficacy and specificity and overcome disadvantages of chemotherapy so as to improve the survival rate of patients. 3. Provide a reliable targeted multimodal formulation, which target and kill cancer cells at a higher efficacy and specificity and reduces drug efflux. 4. Provide a reliable, multimodal formulation comprising a chitosan coated mesoporous nanoparticle loaded with an anticancer agent. 5. provide a reliable, targeted multimodal formulation comprising: chitosan coated mesoporous nanoparticle loaded with an anticancer agent and an aptamer.

    Technology Inputs:

Imported Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Indigenous Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Imported Raw Materials:
Raw Materials Year ITC-HS Code
NA
Indigenous Raw Materials:
Raw Materials Year ITC-HS Code
NA
Existing R&D Facilities used:
Facilities Year ITC-HS Code
NA

   Patents & Publications:

Patents:
Filed Patents (No.) Granted Patents (No.) Year
1 0 2019-20
Publications:
Submitted (No.) Published (No.) Year
0 0 NA

    Commercialization Potential:

Who are the Potential Licensees?
What commercially available products address
the same problem?
Company Product Problem Addressed
Would you like to develop this invention further with
corporate research support?
Yes
Would you be interested in participating in cluster based
programs for commercialization research or business
planning for your invention?
Yes
      Submitted by: J.G. Rao Date of Submission: 4-8-2020



Chat Room      Write Review     Talk to Experts


THE VISION
THE MISSION
ABOUT I-STEM
It has always been the basic tenet of the Government of India, in generously funding R&D efforts at academic institutions over the years, that facilities established through such support be made available to those needing them and qualified to make use of them for their own research work
read more >>

However, this was never easy or straightforward for, among other reasons, there was no ready source of information of what facility was available and where. Thanks to the Web, it is much easier today to have a national and regional “inventory of resources”, so as to match users with the resources they need, and to do all this in an efficient and transparent manner.

This can lead to a leap in R&D productivity and greatly enhance the effectiveness of public investment. This is the motivation behind I-STEM.
read less <<
Visitor Hit Counter
Hosted at Indian Institute of Science
Copyright © 2024 I-STEM. All rights reserved.
Audited by: STQC Bengaluru.